Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
-0.63%
)
US TECH 100
25,895.20
(
0.09%
)
Dow Jones
49,149.38
(
-0.60%
)
Brent Oil
94.21
(
-0.85%
)
Bitcoin
77,465.26
(
1.49%
)
News Focus
News Focus
Post# of 405181
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Ultimate01

Send PM Follow Ignore
Followers 17
Posts 987
Boards Moderated 0
Alias Born 01/24/2013

Ultimate01

Re: loanranger post# 108696

Friday, 06/19/2015 8:12:08 AM

Friday, June 19, 2015 8:12:08 AM

Post# of 405181
Previously treated patients may be confounding. The strongest possible trial design would NOT have patients previously treated because then it may be argued that the effect of B-OM is actually a result of Previous TXs plus B-OM.

Go BRILACIDIN!!!
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote